- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €4295EUR$4,500USD£3,598GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1432EUR$1,500USD£1,199GBP
- Report
- October 2024
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2625EUR$2,750USD£2,199GBP
- Report
- December 2021
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3340EUR$3,500USD£2,799GBP
The Cyclospora Test market is a segment of the In Vitro Diagnostics (IVD) industry. It is used to detect the presence of Cyclospora, a single-celled parasite that can cause gastrointestinal illness. Tests for Cyclospora are typically used to diagnose and monitor the progression of the infection. Tests may be performed on stool, blood, or other bodily fluids.
The Cyclospora Test market is expected to grow due to increasing prevalence of the infection, rising awareness of the disease, and the availability of advanced diagnostic technologies. Additionally, the increasing demand for rapid and accurate diagnosis of the infection is expected to drive the market.
Some companies in the Cyclospora Test market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, DiaSorin, and Hologic. Show Less Read more